Prellis Biologics Appoints New Ceo, Raises $35 Million In Series C Funding To Leverage Human Immune System Biology To De-Risk And Accelerate Therapeutics Drug Discovery And Development
Amount Raised
$35 Million
Round Type
Series C
HaywardInformation TechnologyBiotechnologyDescription
Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round, co-led by Celesta Capital and Avidity Partners with participation from Khosla Ventures, SOSV, True Ventures, and Lucas Venture Group. Dr. Nohaile joins from Generate Biomedicines and succeeds Prellis Bio founder Dr. Melanie Matheu, who will assume the role of Chief Technology Officer and retain a Board seat
Quick answer
Prellis Biologics, Inc raised $35 Million in a Series C round, dated August 10, 2022. Prellis Biologics, Inc is based in Hayward, California, United States.
- How much did Prellis Biologics, Inc raise?
- Prellis Biologics, Inc raised $35 Million in a Series C round on August 10, 2022.
- Where is Prellis Biologics, Inc based and how big is it?
- Prellis Biologics, Inc is based in Hayward, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Prellis Biologics, Inc that raised within 45 days of this round, from Fundz verified event records.
- Endovia Health Sciences, Inc. raised an undisclosed amount (Funding Round) on September 23, 2022.
- Novabay raised $3.3M (Seed) on September 23, 2022.
- CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
- Leuko raised $5M (Series A) on September 23, 2022.
- Surge raised $2.6M (Seed) on September 23, 2022.
- 511 Therapeutics raised $50K (Pre-Seed) on September 23, 2022.
Who to call at Prellis Biologics, Inc, and when
A new round usually means Prellis Biologics, Inc is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Prellis Biologics, Inc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Prellis Biologics, Inc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Prellis Biologics, Inc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Prellis Biologics, Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Prellis Biologics, Inc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.